Key Points
- Director Ronda Stryker sold 310,000 shares of Stryker on May 26 at an average price of $312.23, generating about $96.8 million and reducing her ownership by 13.87%.
- Stryker shares were up 0.4% to $307.22, while the stock has traded between a 52-week low of $281.00 and high of $404.87.
- The company recently reported Q1 earnings and revenue below expectations, with EPS of $2.60 versus $2.98 expected and revenue of $6.02 billion versus $6.34 billion expected; it also announced a quarterly dividend of $0.88 per share.
Stryker Corporation (NYSE:SYK - Get Free Report) Director Ronda Stryker sold 310,000 shares of the firm's stock in a transaction on Tuesday, May 26th. The stock was sold at an average price of $312.23, for a total transaction of $96,791,300.00. Following the transaction, the director directly owned 1,924,880 shares in the company, valued at $601,005,282.40. The trade was a 13.87% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website.
Stryker Trading Up 0.4%
Shares of Stryker stock opened at $307.22 on Friday. Stryker Corporation has a 1 year low of $281.00 and a 1 year high of $404.87. The company has a debt-to-equity ratio of 0.62, a quick ratio of 1.25 and a current ratio of 2.11. The company has a market capitalization of $117.78 billion, a P/E ratio of 35.56, a PEG ratio of 1.93 and a beta of 0.80. The company's fifty day moving average is $322.61 and its two-hundred day moving average is $348.45.
Stryker (NYSE:SYK - Get Free Report) last issued its quarterly earnings data on Thursday, April 30th. The medical technology company reported $2.60 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.98 by ($0.38). Stryker had a return on equity of 23.42% and a net margin of 13.20%.The business had revenue of $6.02 billion for the quarter, compared to analysts' expectations of $6.34 billion. During the same period in the previous year, the business posted $2.84 earnings per share. The company's revenue for the quarter was up 2.6% on a year-over-year basis. Stryker has set its FY 2026 guidance at 14.900-15.100 EPS. Analysts forecast that Stryker Corporation will post 14.98 earnings per share for the current year.
Stryker Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Tuesday, June 30th will be given a dividend of $0.88 per share. This represents a $3.52 annualized dividend and a yield of 1.1%. The ex-dividend date of this dividend is Tuesday, June 30th. Stryker's dividend payout ratio (DPR) is presently 40.74%.
Wall Street Analyst Weigh In
Several brokerages have issued reports on SYK. Citigroup dropped their price objective on shares of Stryker from $420.00 to $385.00 and set a "buy" rating on the stock in a research note on Tuesday, April 7th. Leerink Partners started coverage on shares of Stryker in a research note on Monday, April 13th. They issued an "outperform" rating and a $410.00 price objective on the stock. Barclays lowered their target price on shares of Stryker from $469.00 to $394.00 and set an "overweight" rating on the stock in a report on Monday, May 4th. Wall Street Zen downgraded shares of Stryker from a "buy" rating to a "hold" rating in a report on Saturday, May 16th. Finally, The Goldman Sachs Group reaffirmed a "neutral" rating and issued a $361.00 target price on shares of Stryker in a report on Friday, May 1st. Sixteen research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $395.48.
Read Our Latest Research Report on SYK
Institutional Trading of Stryker
Hedge funds and other institutional investors have recently made changes to their positions in the company. Godfrey Financial Associates Inc. purchased a new stake in shares of Stryker in the fourth quarter valued at about $26,000. Sankala Group LLC purchased a new stake in shares of Stryker in the fourth quarter valued at about $26,000. United Financial Planning Group LLC purchased a new stake in Stryker during the third quarter worth about $27,000. Atlas Capital Advisors Inc. purchased a new stake in Stryker during the fourth quarter worth about $27,000. Finally, DJE Kapital AG purchased a new stake in Stryker during the fourth quarter worth about $28,000. Hedge funds and other institutional investors own 77.09% of the company's stock.
About Stryker
(
Get Free Report)
Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons' offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
